Featured Press Releases
ICER Publishes Protocol for First Annual Assessment of Drug Coverage Policies That Present Barriers to Fair Access
ICER’s analysis will evaluate how 15 of the largest US payers provide coverage for 28 cost-effective prescription drugs.
05/25/2021ICER Issues Statement on the FDA’s Approval of Aducanumab for Alzheimer’s Disease
Our review of the evidence was concordant with that of many independent experts: current evidence is insufficient to demonstrate that aducanumab benefits patients.
06/07/2021ICER Analytics™ Launched to Accelerate the Real-World Application of ICER Reports, Helping Payers, the Life Science Industry, and Health Care Policy Makers Move From Insight to Action
ICER formally launched ICER Analytics™, a new cloud-based platform that will revolutionize the ability of payers, life science companies, patient groups, and others to develop formularies, negotiate drug prices.
11/30/2020